Skip to main content
. Author manuscript; available in PMC: 2024 Jan 1.
Published in final edited form as: Int Forum Allergy Rhinol. 2023 Mar 30;13(7):1061–1482. doi: 10.1002/alr.23079

TABLE VIII.C.2.a.

Summary of evidence for mandibular repositioning device efficacy versus CPAP

Study Year LOE (1a–5) Study design Study groups Clinical endpoint Conclusion
Bratton et al.1380 2015a 1a Network meta-analysis 1. MRD
2. CPAP
3. Control
67 Studies6873 Subjects
Epworth Sleepiness Score CPAP more effective than MRD in reducing ESS (although possibility of publication bias in favor of CPAP that may contribute to difference)
Bratton et al.1208 2015b 1a Network meta-analysis 1. MRD
2. CPAP
3. Control
51 Studies4888 Subjects
Blood pressure Both MRD and CPAP reduce BP relative to control. There was no difference in BP reduction between CPAP and MRD
Kuhn et al.1381 2017 1a Systematic review and meta-analysis 1. MRD
2. CPAP
23 Studies2342 Subjects
SF-36 (mental and physical components) Suggestive that MRD may be similarly effective to CPAP, but more RCTs needed
Ramar et al.809 2015 1a Clinical practice guideline 1. MRD
2. CPAP
15 Studies491 Subjects
Polysomnographic indices, adherence, side effects, blood pressure, quality of life, sleepiness It is recommended that MRD is prescribed for adult OSA patients, rather than no therapy, who are intolerant of CPAP or prefer alternative therapy
Schwarz et al.1385 2018 1a Systematic review and meta-analysis 1. CPAP
2. MAS
12 (824) [AHI]Six (525) [compliance]Four (559) [FOSQ]10 (950) [ESS]Two (244) [cognitive function]
1. AHI
2. Compliance
3. FOSQ
4. ESS
5. Cognitive function
CPAP better reducing AHI. No difference SF-36, FOSQ, cognitive performance. ESS potentially favors CPAP, adherence greater in MRD

Abbreviations: AHI, apnea hyponea index; BP, blood pressure; CPAP, continuous positive airway pressure; ESS, Epworth Sleepiness Score; FOSQ, Functional Outcomes of Sleep Questionnaire; MRD, mandibular repositioning.